Vlaskou Badra Eugenia, Ermiş Ekin, Mordasini Pasquale, Herrmann Evelyn
Department of Radiation Oncology, Bern University Hospital, University of Bern, Bern, Switzerland.
University Institute of Diagnostic and Interventional Neuroradiology, Bern University Hospital, University of Bern, Bern, Switzerland.
J Neurosurg Sci. 2018 Aug;62(4):490-504. doi: 10.23736/S0390-5616.18.04406-5. Epub 2018 Mar 26.
Arteriovenous malformations (AVMs) are rare congenital vascular pathologies. The reported overall annual hemorrhage rate is 3.0%, for unruptured AVMs it is 2.2%, and for ruptured AVMs, 4.5%. The main goal of AVM treatment is to prevent intracerebral hemorrhage. This is achieved by complete nidus eradication. Interventional treatment options include microsurgery, embolization and radiosurgery, as well as multimodal approaches. Radiosurgery is a safe and effective alternative to surgery or embolization, especially for AVMs located in deep or eloquent brain regions, where invasive treatment cannot be performed. With the introduction of the Leksell Gamma Knife, AVMs became one of the most common indications for radiosurgical interventions (nearly 30% of the first 15-year experience). The current review discusses the role of radiosurgery in the treatment of AVMs, with a focus on outcome predictors and a discussion of the relevant literature.
动静脉畸形(AVM)是罕见的先天性血管病变。报道的总体年出血率为3.0%,未破裂AVM的年出血率为2.2%,破裂AVM的年出血率为4.5%。AVM治疗的主要目标是预防脑出血。这通过彻底根除病灶来实现。介入治疗选择包括显微手术、栓塞和放射外科,以及多模式方法。放射外科是手术或栓塞的一种安全有效的替代方法,特别是对于位于深部或脑功能区的AVM,这些部位无法进行侵入性治疗。随着Leksell伽玛刀的引入,AVM成为放射外科干预最常见的适应症之一(在前15年的经验中占近30%)。本综述讨论了放射外科在AVM治疗中的作用,重点是预后预测因素并对相关文献进行讨论。